Rectal bleeding and diarrhea caused by bortezomib-induced colitis.
Nogales Rincón
Oscar
O
Huerta Madrigal
Alain
A
Merino Rodriguez
Beatriz
B
González Asanza
Cecilia
C
Cos Arregui
Enrique
E
Menchén Fernández-Pacheco
Pedro
P
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001897:Boronic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D000069286:Bortezomib; D003092:Colitis / Q000139:chemically induced* / Q000150:complications; D003967:Diarrhea / Q000209:etiology*; D006471:Gastrointestinal Hemorrhage / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors; D061988:Proteasome Inhibitors; D047428:Protein Kinase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011719:Pyrazines / Q000009:adverse effects* / Q000627:therapeutic use; D012007:Rectum
D000970:Antineoplastic Agents; D001897:Boronic Acids; D009363:Neoplasm Proteins; D061988:Proteasome Inhibitors; D047428:Protein Kinase Inhibitors; D011719:Pyrazines; D000069286:Bortezomib